This grant, offered by the National Institutes of Health (NIH), is designed to foster the development of groundbreaking tuberculosis (TB) vaccine candidates. Its primary purpose is to support the conceptualization and initial design of novel vaccine approaches, followed by their rigorous advancement into preclinical animal model testing. The program specifically seeks innovative strategies that can significantly improve current TB vaccine discovery efforts. Funding is structured as a unique, milestone-driven, biphasic award, ideal for high-risk and exploratory research endeavors. Progression from the initial phase to the subsequent phase is contingent upon the successful achievement of predefined research milestones, ensuring a focused and results-oriented approach to accelerating TB vaccine innovation.
Opportunity ID: 331614
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-21-007 |
| Funding Opportunity Title: | Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 19, 2021 |
| Last Updated Date: | Feb 19, 2021 |
| Original Closing Date for Applications: | Jun 30, 2021 |
| Current Closing Date for Applications: | Jun 30, 2021 |
| Archive Date: | Aug 05, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Special district governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | To support the design of novel tuberculosis (TB) vaccine candidates that exploit innovative approaches and their advancement into preclinical animal model testing. This funding opportunity will use a milestone driven, biphasic award mechanism to fund high risk/exploratory research. Transition to the second phase depends on the successful completion of milestones. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00265563 | May 30, 2021 | Jun 30, 2021 | View |
Package 1
Mandatory forms
331614 RR_SF424_2_0-2.0.pdf
331614 PHS398_CoverPageSupplement_5_0-5.0.pdf
331614 RR_OtherProjectInfo_1_4-1.4.pdf
331614 PerformanceSite_2_0-2.0.pdf
331614 RR_KeyPersonExpanded_2_0-2.0.pdf
331614 RR_Budget_1_4-1.4.pdf
331614 PHS398_ResearchPlan_4_0-4.0.pdf
331614 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331614 RR_SubawardBudget30_1_4-1.4.pdf
331614 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
